COM:NRXPHARMA
NRx Pharmaceuticals
- Stock
Last Close
1.23
22/11 21:00
Market Cap
25.25M
Beta: -
Volume Today
79.66K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
net income | 66.10K - | 408.43K 517.88% | -51.78M 12,777.17% | -93.06M 79.74% | -39.75M 57.28% | -30.15M 24.16% | ||
depreciation and amortization | 0.86 - | 2K 232,728.87% | 2K 0% | 4K 100% | 5K 25% | |||
deferred income tax | 70.41K - | 5.72M 8,019.93% | -1.81M 131.71% | -2.65M - | ||||
stock based compensation | 933.90 - | 730K 78,066.49% | 7.79M 966.44% | 3.63M 53.40% | 387K 89.33% | |||
change in working capital | -35.51K - | -980.42K 2,660.97% | 4.66K 100.48% | 3.45M 73,966.92% | -4.90M 241.85% | 699K 114.27% | 5.16M 638.77% | |
accounts receivables | -831K - | 831K 200% | ||||||
inventory | ||||||||
accounts payables | 465.43K - | 71.34K 84.67% | 1.18M 1,558.21% | -19K 101.61% | -1.61M 8,378.95% | 2.65M 264.80% | ||
other working capital | -35.51K - | -1.45M 3,971.67% | -66.68K 95.39% | 3.10M 4,750.57% | -5.71M 284.13% | 2.31M 140.46% | 2.51M 8.61% | |
other non cash items | -100.30K - | 441.13K 539.81% | -1.28M 389.52% | 39.61M 3,201.41% | 54.28M 37.05% | -4.33M 107.98% | 5.59M 229.09% | |
net cash provided by operating activities | -135.81K - | -473.19K 248.42% | -792.73K 67.53% | -2.27M 185.72% | -37.70M 1,564.59% | -39.76M 5.44% | -21.66M 45.52% | |
investments in property plant and equipment | -3.55 - | -2K 56,206.31% | -7K 250% | -10K 42.86% | ||||
acquisitions net | ||||||||
purchases of investments | -690K - | -993.10K 43.93% | -7K - | -10K 42.86% | -3K 70% | |||
sales maturities of investments | 42.39K - | 41.24M 97,181.75% | ||||||
other investing activites | -69M - | 3.55 - | 7K - | 10K 42.86% | ||||
net cash used for investing activites | -69M - | -647.61K 99.06% | 40.25M 6,314.65% | -2K 100.00% | -7K 250% | -10K 42.86% | -3K 70% | |
debt repayment | -1.26M - | -620K 50.86% | -1.28M 105.81% | -518K 59.40% | -3.09M 496.91% | |||
common stock issued | 2.58M - | 36.98M 1,334.01% | 22.70M 38.62% | 9.29M 59.07% | ||||
common stock repurchased | 70.03M - | -40.73M - | ||||||
dividends paid | ||||||||
other financing activites | -439.92K - | 682.50K 255.14% | 5.80K 99.15% | 1.29M 22,133.70% | 27.75M 2,051.09% | 10.03M 63.85% | 5.03M 49.85% | |
net cash used provided by financing activities | 69.59M - | 682.50K 99.02% | -39.46M 5,882.41% | 3.25M 108.23% | 63.46M 1,853.09% | 32.21M 49.23% | 6.20M 80.75% | |
effect of forex changes on cash | 11.95K - | |||||||
net change in cash | 449.37K - | -438.30K 197.54% | -11.07K 97.47% | 982K 8,968.42% | 25.75M 2,521.79% | -7.55M 129.33% | -15.46M 104.73% | |
cash at beginning of period | 449.37K - | 11.08K 97.53% | 877K 7,815.88% | 1.86M 111.97% | 27.61M 1,384.94% | 20.05M 27.35% | ||
cash at end of period | 449.37K - | 11.08K 97.53% | 6 99.95% | 1.86M 30,983,233.33% | 27.61M 1,384.94% | 20.05M 27.35% | 4.59M 77.09% | |
operating cash flow | -135.81K - | -473.19K 248.42% | -792.73K 67.53% | -2.27M 185.72% | -37.70M 1,564.59% | -39.76M 5.44% | -21.66M 45.52% | |
capital expenditure | -3.55 - | -2K 56,206.31% | -7K 250% | -10K 42.86% | ||||
free cash flow | -135.81K - | -473.19K 248.42% | -792.73K 67.53% | -2.27M 185.97% | -37.71M 1,563.43% | -39.77M 5.45% | -21.66M 45.54% |
All numbers in (except ratios and percentages)